- “Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial” (Press release issued by Teva Pharmaceuticals, PR-Inside.com)
- “New Cancer Drug Reports Success in Trials” (Top News – United States)
- “Pfizer’s Sutent effective vs rare pancreatic cancer” (Reuters)
- “Global Skin Lighteners Market to Reach $10 Billion by 2015” (Grinza)
- “Japan approves first generic biotech drug” (Reuters)
- “Little Pill Offers New Hope in Breast Cancer Battle” (NBC DWF/Health)
- “Faes talking to Pfizer over allergy drug bilastine” (PharmaTimes)
- “Asthma patients struggling to afford essential drugs, studies show” (PharmaTimes)
THE LATEST WORD
Top Industry Stories – June 25, 2009
Posted on June 25th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics